Carey Anders

Durham, North Carolina

Contributor at Freelance

Medical oncologist, Medical Director of the Duke Brain and Spine Metastases Center, Duke Cancer Institute, Durham, NC

Featured in: Favicon

nature.com Favicon

wiley.com (+1) Favicon

tandfonline.com Favicon

medscape.com Favicon

thelancet.com Favicon

healio.com Favicon

aacrjournals.org Favicon

ascopubs.org Favicon

futuremedicine.com Favicon

cancernetwork.com + 4 more

Articles

Impact of systemic disease on CNS disease control after stereotactic radiosurgery to breast cancer brain metastases (The SYBRA Study) - npj Breast Cancer

Aug 1, 2024 | nature.com | Alex Schick |Myla S. Strawderman |Sarah L. Sammons |Carey Anders

AbstractThe objective of the study is to assess impact of systemic disease (SD) status on overall survival and brain metastasis (BM) control, adopting a novel landmark approach to categorize SD among breast cancer (BC) patients. This single institution retrospective study included BCBM patients who have received stereotactic radiosurgery (SRS) to brain.
Radiation Necrosis with ADCs and Concurrent Radiotherapy for Brain Metastases

Mar 1, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512
Patient Case Presentation: A 34-Year-Old Woman with HER+ mBC and Brain Metastases

Feb 23, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512
BRIDGET: Preventing Secondary Brain Metastases in Advanced HER2+ Breast Cancer

Feb 16, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512
Patient Case Presentation: A 34-Year-Old Woman with HER2+ mBC and Brain Metastases

Feb 16, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512
HER2CLIMB: Targeting Stable and Active Brain Metastases in Advanced HER2+ Breast Cancer

Feb 16, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512
Treatment Approaches for Triple-Positive mBC in the 2L Setting and Beyond

Feb 9, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512
The Role of Radiotherapy in HER2+ mBC

Feb 9, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512
Approaches for 1L Therapy and Restaging in Triple-Positive mBC

Jan 5, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

Approaches for 1L Therapy and Restaging in Triple-Positive mBCSusan Dent, MD, delves into the exploration of front-line treatment options for triple-positive breast cancer and examines strategies for restaging in the event of disease progression after first-line therapy.
Advancements in Treatment Strategies for HER2+ Metastatic Breast Cancer: Insights from Experts at the Duke Cancer Center

Dec 17, 2023 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

Advancements in Treatment Strategies for HER2+ Metastatic Breast Cancer: Insights from Experts at the Duke Cancer CenterIn this Cancer Network Around the Practice program, Susan Dent, MD discusses the case of a 66-year-old patient with grade 3 triple-positive breast cancer who presents with multiple liver and bone metastases after front-line treatment with trastuzumab and letrozole.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers: 646
Tweets: 6
DMs Open: No

No Tweets found.